文献速递关节外科

一期或两期髋关节翻修?一期手术的高死亡率挑战其日益增长的普及性:一项登记研究

One- or Two-Stage Hip Revision? High Mortality in One-Stage Challenges Its Growing Popularity: A Registry Study.
PubMed 文献 · J Arthroplasty · 2025-08-19

该观察性队列研究利用德国内置假体登记数据(2013至2023年)比较一期与两期翻修全髋关节置换术的再翻修率和死亡率。首次翻修中,一期组1年死亡率高于两期组(9.9% vs 6.3%,P=0.014),5年死亡率无显著差异;多次翻修中,一期组1年和5年死亡率均更高。结论指出,尽管一期翻修在大型中心结果优异,但全国数据显示其死亡率显著更高,不能推荐广泛使用。

要点

  • 首次翻修全髋关节置换术中,一期组1年死亡率9.9%高于两期组6.3%(P=0.014)。
  • 多次翻修全髋关节置换术中,一期组1年死亡率12.8%高于两期组5.5%(P<0.001)。
  • 多次翻修中,一期组再翻修率1年26.5% vs 21.0%、5年32.2% vs 26.5%(P=0.001)。

核心结论

  • 尽管个别大型中心报告一期翻修全髋关节置换术结果优异,但全国数据显示该手术死亡率显著更高。
  • 这一差异引发了对在专科中心之外更广泛开展的担忧。
  • 一年内的显著差异表明一期翻修的围手术期死亡率增加。
  • 尽管再翻修率相当,但死亡率风险增加提示一期入路不能推荐广泛使用。

研究设计与样本

  • 该观察性队列研究使用德国内置假体登记数据(2013至2023年),比较一期与两期翻修全髋关节置换术的再翻修率和死亡率。
  • 病例包括首次翻修全髋关节置换术(一期:n=12,418;两期:n=1,000)和多次翻修全髋关节置换术(一期:n=2,459;两期:n=810)。
  • 采用Kaplan-Meier估计进行分析。

主要发现

  • 首次翻修全髋关节置换术后5年再翻修率相近(一期21.1% vs 两期19.9%,P=0.068),但一期1年再翻修率略高(16.1% vs 14.1%,P=0.022)。
  • 多次翻修中,一期再翻修率更高(1年:26.5% vs 21.0%;5年:32.2% vs 26.5%,P=0.001)。
  • 首次翻修全髋关节置换术后1年死亡率一期更高(9.9% vs 6.3%,P=0.014),但5年死亡率无显著差异(26.5% vs 23.9%,P=0.077)。
  • 多次翻修全髋关节置换术中,一期组死亡率持续更高(1年:12.8% vs 5.5%,P<0.001;5年:31.9% vs 23.7%,P=0.008)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprosthetic joint infection is a severe complication after hip arthroplasty. While one-stage revision is increasingly used in Germany and other countries, the two-stage procedure remains the gold standard in much of the world. Meta-analyses report comparable or superior success rates for one-stage procedures, but it is unclear whether results from large orthopaedic centers can be reproduced in registry data reflecting broader clinical practice. METHODS: This observational cohort study used German Endoprosthesis Registry data (2013 to 2023) to compare re-revision and mortality rates between one-stage and two-stage revision total hip arthroplasty (RTHA). Cases included first-time RTHA (one-stage: n = 12,418; two-stage: n = 1,000) and multiple RTHA (one-stage: n = 2,459; two-stage: n = 810). Kaplan-Meier estimates were applied for analysis. RESULTS: Re-revision rates after first-time RTHA were similar at five years (21.1% one-stage versus 19.9% two-stage, P = 0.068), though slightly higher at one year for one-stage (16.1% versus 14.1%, P = 0.022). In multiple revisions, one-stage showed higher re-revision rates (one year: 26.5 versus 21.0%; five years: 32.2 versus 26.5%, P = 0.001). Mortality after first-time RTHA was higher for one-stage at one year (9.9 versus 6.3%, P = 0.014), but not significant at five years (26.5 versus 23.9%, P = 0.077). In multiple RTHA, mortality remained higher in the one-stage group (one year: 12.8 versus 5.5%, P < 0.001; five years: 31.9 versus 23.7%, P = 0.008). CONCLUSIONS: Despite the excellent results reported for one-stage RTHA by individual large centers, nationwide data show significantly higher mortality rates in this procedure. This discrepancy raises concerns about broader implementation outside of specialized centers. Significant differences within the first year indicate an increased perioperative mortality for one-stage revision. While the re-revision rates are comparable, the increased mortality risk suggests that the one-stage approach cannot be recommended for wide use.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Resl M, Becker L, Wu Y, et al. One- or Two-Stage Hip Revision? High Mortality in One-Stage Challenges Its Growing Popularity: A Registry Study. J Arthroplasty. 2025. PMID: 40840657. doi:10.1016/j.arth.2025.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。